Home Cart Sign in  
Chemical Structure| 71203-35-5 Chemical Structure| 71203-35-5

Structure of ML141
CAS No.: 71203-35-5

Chemical Structure| 71203-35-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.

Synonyms: CID-2950007

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML141

CAS No. :71203-35-5
Formula : C22H21N3O3S
M.W : 407.49
SMILES Code : O=S(C1=CC=C(N2N=C(C3=CC=CC=C3)CC2C4=CC=C(OC)C=C4)C=C1)(N)=O
Synonyms :
CID-2950007
MDL No. :MFCD05987165
InChI Key :QBNZBMVRFYREHK-UHFFFAOYSA-N
Pubchem ID :2950007

Safety of ML141

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of ML141

GPCR

Isoform Comparison

Biological Activity

Target
  • Cdc42-subclass

    cdc42, IC50:200 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 10 µM 2 hours Suppression of Cdc42 reduced the LPS-stimulated expressions of IL6, TNF-α, and IL1β, indicating that ML141 inhibited M1-type macrophage polarization. Cell Mol Gastroenterol Hepatol. 2024;17(6):965-981.
THP1 cells 10 µM 2 hours Inhibition of Cdc42 activities reduced the expression of M1 polarization markers CD86 and CD64, while increasing the expression of M2 polarization marker CD206, indicating that ML141 promoted M2-type macrophage polarization. Cell Mol Gastroenterol Hepatol. 2024;17(6):965-981.
Vascular smooth muscle cells 10 µM 20 hours ML141 reduced OPN elevation in LRP6-deficient VSM Circ Res. 2015 Jul 3;117(2):142-56.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice BALB/c mice Intraperitoneal injection 1 mg/ml Daily for 3 weeks To investigate the effect of Cdc42 inhibition on podocyte apoptosis, the results showed that Cdc42 inhibition led to increased podocyte apoptosis and proteinuria. Cell Death Dis. 2016 Mar 17;7(3):e2142
Mice Hepatic ischemia-reperfusion injury model Peritoneal injection 10 mg/kg Every 12 hours, twice Inhibition of Cdc42 significantly alleviated hepatic ischemia-reperfusion injury, inhibited the infiltration of monocyte-derived macrophages, reduced M1 macrophages, and increased M2 macrophages. Cell Mol Gastroenterol Hepatol. 2024;17(6):965-981.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.45mL

0.49mL

0.25mL

12.27mL

2.45mL

1.23mL

24.54mL

4.91mL

2.45mL

References

 

Historical Records

Categories